Replimune Group, Inc.

DB:7R8 Stock Report

Market Cap: €131.2m

Replimune Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Sush Patel

Chief executive officer

US$3.7m

Total compensation

CEO salary percentage16.23%
CEO tenure2yrs
CEO ownership0.09%
Management average tenure2yrs
Board average tenure5.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sush Patel's remuneration changed compared to Replimune Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$315m

Sep 30 2025n/an/a

-US$310m

Jun 30 2025n/an/a

-US$280m

Mar 31 2025US$4mUS$600k

-US$247m

Dec 31 2024n/an/a

-US$228m

Sep 30 2024n/an/a

-US$213m

Jun 30 2024n/an/a

-US$220m

Mar 31 2024US$2mUS$465k

-US$216m

Dec 31 2023n/an/a

-US$210m

Sep 30 2023n/an/a

-US$199m

Jun 30 2023n/an/a

-US$182m

Mar 31 2023US$3mUS$447k

-US$174m

Dec 31 2022n/an/a

-US$157m

Sep 30 2022n/an/a

-US$147m

Jun 30 2022n/an/a

-US$133m

Mar 31 2022US$7mUS$394k

-US$118m

Compensation vs Market: Sush's total compensation ($USD3.70M) is above average for companies of similar size in the German market ($USD867.73K).

Compensation vs Earnings: Sush's compensation has increased whilst the company is unprofitable.


CEO

Sush Patel (54 yo)

2yrs
Tenure
US$3,697,661
Compensation

Dr. Sushil Patel, also known as Sush, Ph D, is CEO & Director of Replimune Group, Inc. from April 1, 2024. Dr. Patel served as the Chief Commercial Officer at Replimune Group, Inc. since May 3, 2021 and se...


Leadership Team

NamePositionTenureCompensationOwnership
Sushil Patel
CEO & Director2yrsUS$3.70m0.086%
€ 113.3k
Emily Hill
Chief Financial Officer2.6yrsUS$1.59m0.034%
€ 44.0k
Konstantinos Xynos
Chief Medical Officer3.3yrsUS$1.62m0.053%
€ 69.2k
Philip Astley-Sparke
Executive Chairman11.3yrsUS$6.02m1.56%
€ 2.1m
Andrew Schwendenman
Chief Accounting Officer & Treasurer2.9yrsno data0.018%
€ 23.4k
Shawn Glidden
Senior VP & General Counsel1.2yrsno datano data
Camilo Garcia
Chief Human Resource Officer1.2yrsno datano data
Christopher Sarchi
Chief Commercial Officer3.3yrsno data0.036%
€ 47.5k
Paul Bullock
Chief Manufacturing Officer & Framingham Site Head2.3yrsno datano data
Nina Aragam
Senior Vice President of Portfolio Strategy & Program Management1.2yrsno datano data
Carolyn Trott
Senior Vice President of Quality Assurance2yrsno datano data
Kari Jeschke
Senior Vice President of Regulatory Affairs1.2yrsno datano data
2.0yrs
Average Tenure
54yo
Average Age

Experienced Management: 7R8's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Sushil Patel
CEO & Director2yrsUS$3.70m0.086%
€ 113.3k
Philip Astley-Sparke
Executive Chairman11.3yrsUS$6.02m1.56%
€ 2.1m
Joseph Slattery
Independent Director8.5yrsUS$240.16k0.0081%
€ 10.6k
Michael Goller
Independent Director1.1yrsUS$543.13kno data
Paolo Pucci
Independent Director6yrsUS$227.42k0%
€ 0
Madhavan Balachandran
Independent Director1.6yrsUS$486.71kno data
Kapil Dhingra
Independent Director8.8yrsUS$235.16k0%
€ 0
Christy Oliger
Independent Director4.3yrsUS$234.26k0%
€ 0
Dieter Weinand
Lead Independent Director7.8yrsUS$264.05k0%
€ 0
Veleka Peeples-Dyer
Independent Director2.8yrsUS$227.66k0%
€ 0
5.2yrs
Average Tenure
57.5yo
Average Age

Experienced Board: 7R8's board of directors are considered experienced (5.2 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/22 09:26
End of Day Share Price 2026/04/22 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Replimune Group, Inc. is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Clarence PowellBMO Capital Markets Equity Research
Evan SeigermanBMO Capital Markets Equity Research
Guyn KimBMO Capital Markets Equity Research